In 1991, Mark Beers, MD, and colleagues at University of California Los Angeles developed the Beers Criteria to identify potentially inappropriate medication (PIM) for nursing home residents. Since their initial release, the Beers Criteria has been updated six times and expanded the criteria to apply to all adults 65 years and older.

Daniel A. Hussar, PhD

Job-related stress and burnout are at all-time highs across professions. In the 2023 American Psychological Association (APA) Work in America Survey, 77% of workers reported experiencing work-related stress in the last month, and 57% reported experiencing negative impacts because of work-related stress.

Cynthia Knapp Dlugosz, BSPharm, NBC-HWC, Artemis Health Care Communications, Ann Arbor, MI

It is estimated that approximately 7,000 to 9,000 patients die every year in the United States due to medication errors, such as the one described in this case study.

Ronald Zentz, RPh, DDS, FAGD, CPHRM, Consulting Director, CNA Specialty Risk Control, CNA Insurance, Chicago, IL,
and Georgia Reiner, MS, CPHRM, Risk Analyst, Healthcare Providers Service Organization, Fort Washington, PA

It’s natural! Yet, as with any substance, chemical, and medication on this planet, it comes with its own baggage. Hence the circular and polarized conversations emanating across our country and globe.

Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, WVU School of Pharmacy, Morgantown, WV

There are an estimated 100,000 to 300,000 OTC products on the market in the United States.

Kelly L. Scolaro, PharmD

The legislative, regulatory, societal, and economic issues impacting the pharmacy community in 2023 resulted in some wins, some losses, and some continuing challenges that will carry into 2024.

Gluten-related disorders, including but not limited to celiac disease, non-celiac gluten sensitivity (NCGS), and wheat allergy, affect millions of people worldwide with an estimated global prevalence of about 5%.

Jamie Huff, PharmD

The traditional health care model requires the patient to seek care by coming to the health system (e.g., office, hospital, pharmacy, etc.). Health care providers often do not represent or have the lived experiences of the communities they serve, which can lead to overt and implicit bias within the health care system. These structural and political determinants of health further reinforce relationships that contribute to a problematic power dynamic that exacerbates long-standing health disparities primarily for communities who are underserved, notably Black, Indigenous, and people of color populations.

Jasmine D. Gonzalvo, PharmD, CDCES, FADCES

FDA approved 55 new drugs in 2023. Twenty-eight (51%) of these new drugs received orphan drug designation because they are used in the treatment of patients with rare diseases. Five new therapeutic agents are considered in this review, the first in a two-part series of articles on new therapeutic agents approved in 2023: bexagliflozin (Brenzavvy-TheracosBio ), sotagliflozin (lnpefa- Lexicon), zavegepant hydrochloride (Zavzpret- Pfizer)/ lecanemab-irmb (Leqembi-Eisai; Biogen), and fezolinetant (Veozah-Astellas).

Daniel A. Hussar, PhD